TerminatedNCT00486798
FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute Psychosis
Medication studyAges 18–65SwedenSchizophrenia
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- Borås and 12 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateMay 2007
- Recruitment status
- Terminated
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- AstraZeneca
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug, PROCEDURE
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Sweden
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00486798
- Official title
Show the full official title
FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute Psychosis
Recruitment & locations
TerminatedBorås · Danderyd · Falköping
10 more locations
- Gothenburg
- Karlskrona
- Malmö
- Öjebyn
- Piteå
- Simrishamn
- Stockholm
- Trollhättan
- Vaxjo
- Västerås
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is AstraZeneca.
Does this study involve medication?
Yes. The study involves medication, including Quetiapine.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as terminated.
Want to explore more studies?
Explore studiesRelated studies
Add-on treatment of mental illness with anti-viral medicine
FAST – A randomised, open-label, parallel, multicentre Phase IIIb Study to evaluate the Efficacy and Safety of Quetiapine IR titrared over 4 Days in Patients with Acute Psychosis (Rapid versus Conv...